PTX prescient therapeutics limited

Ann: March 2025 Quarterly Update and Appendix 4C, page-7

  1. 1,617 Posts.
    lightbulb Created with Sketch. 637
    PTX shareholders should take a cold hard look at the quarterly of PAB
    The destruction of shareholder value on display there is a direct result of the incompetence of your new Chair James Campbell.

    For the sake of the patients that may benefit from PTXs promising asset I hope the CEO has a backbone and confines Campbell to just reading the script at the AGM
    Shareholders would be well advised to remove Campbell at the first opportunity.
    Last edited by Cornhulio: 30/04/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
4.9¢
Change
-0.003(5.77%)
Mkt cap ! $39.46M
Open High Low Value Volume
5.2¢ 5.2¢ 4.9¢ $46.31K 904.1K

Buyers (Bids)

No. Vol. Price($)
1 13542 4.9¢
 

Sellers (Offers)

Price($) Vol. No.
5.0¢ 8435 1
View Market Depth
Last trade - 14.12pm 16/06/2025 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.